The New Jersey Viatical Settlements Act, Explained

Why New Jersey Has a Viatical Settlements Act at All

The right to sell a life insurance policy is older than the statute by nearly a century. In Grigsby v. Russell, 222 U.S. 149 (1911), the U.S. Supreme Court held that life insurance is ordinary property, transferable like any other asset. What the twentieth century lacked was a rulebook for the market that eventually grew around that right.

The market arrived in the late 1980s, when the AIDS crisis created urgent demand: terminally ill policyholders needed cash for care, and investors would pay for policies with short expected durations. These “viatical” settlements (from viaticum, provisions for a journey) were followed in the 1990s and 2000s by the broader life settlement market serving older insureds who were not dying but simply no longer needed their coverage. Early abuses — hidden commissions, sham valuations, pressure tactics, and stranger-originated insurance schemes — pushed states to act.

New Jersey responded with its Viatical Settlements Act, aligning broadly with the national framework the NAIC developed in its Life Settlements Model Act. The Act’s architecture rests on four pillars: licensing (only vetted parties may broker or buy policies), disclosure (sellers must see the price, the commissions, and the consequences in writing), transactional safeguards (approved forms, escrow, privacy, rescission), and fraud prohibition (STOLI bans and penalties). Because regulation of this market is state-by-state — there is no federal life settlement statute — the Act is effectively the entire rulebook for New Jersey residents. How the fifty-state patchwork fits together is covered in life settlement regulation by state.

One Word, Two Transactions: What “Viatical Settlement” Covers in NJ

The Act’s most confusing feature is vocabulary. Industry usage distinguishes two transactions:

• Viatical settlement (narrow sense): the sale of a policy insuring someone who is terminally or chronically ill — historically the market’s origin, and the version with special tax treatment (proceeds are often tax-free under IRC 101(g) when life expectancy is under 24 months).
• Life settlement: the sale of a policy insuring an older person — typically 65-plus — who is not terminally ill but no longer needs or can afford the coverage.

New Jersey’s statute uses “viatical settlement” as the umbrella label for both. The definitional section sweeps in agreements to sell a policy for compensation less than the expected death benefit, regardless of the insured’s health status. Practically, this means:

• A healthy 78-year-old in Cherry Hill selling a $750,000 universal life policy is entering a “viatical settlement” under New Jersey law, even though the industry — and every other article you will read — calls it a life settlement.
• The Act’s protections (licensing, disclosure, escrow, rescission) apply identically to both transactions. Health status changes the tax outcome and some timing rules, not the regulatory ones.
• When verifying a company with DOBI, search for viatical settlement broker and provider licenses — that is the license category New Jersey issues.

The definitions also carve out what the Act does not cover: assignments to insurers themselves (surrenders), collateral assignments to lenders in ordinary financing, and accelerated death benefits paid by the carrier under a policy rider. Those transactions have their own rules. For the transaction basics before diving deeper into the statute, see what is a life settlement.

The Licensing Backbone: Brokers and Providers

Everything else in the Act hangs on its licensing requirement. Two professional roles must hold DOBI licenses to operate in New Jersey:

• Viatical settlement brokers negotiate settlements on behalf of the policyholder. The statutory design makes the broker the seller’s representative — compensated for finding the best available offer, not for steering policies to a favored buyer. Brokers must meet application, fee, and background requirements, and their compensation must be disclosed to the seller in writing.
• Viatical settlement providers are the buyers — entities that enter settlement contracts with policyholders, pay the purchase price, take ownership, continue premiums, and collect the death benefit. Providers face entity-level licensing: applications, fees, disclosure of officers and control persons, and ongoing obligations including the use of contract forms reviewed by the Department and periodic reporting.

Licensing does three jobs at once. It screens entrants (applicants with fraud histories can be refused), it creates leverage (licenses can be suspended or revoked for violations, and DOBI can fine licensees), and it produces a public record that consumers can check before engaging anyone — the verification steps are laid out in NJ DOBI life settlement licensing: how to verify a broker or provider.

Note who does not need a settlement license: the policyholder selling their own policy, and professionals like attorneys or accountants advising a client in their ordinary capacity. The net is aimed at those transacting or intermediating for compensation. Anyone doing that without a license is violating the Act — full stop — and any transaction they touch loses the paper trail and accountability the statute exists to guarantee. Contact information for the Department is at state.nj.us/dobi.

What Sellers Must Be Told: The Disclosure Provisions

The Act’s disclosure requirements are its most consumer-visible feature. Before a New Jersey policyholder signs a settlement contract, they must receive written disclosures that include, in substance:

• The gross purchase price and how it compares to what the seller will actually receive after any deductions.
• Broker compensation — the amount or method of the commission, so the seller can see what intermediation costs.
• Alternatives to settlement — surrender, policy loans, reduced paid-up coverage, accelerated death benefits — so a sale is a choice among options rather than a default.
• Consequences of selling: possible tax liability, potential loss of eligibility for means-tested public benefits such as Medicaid, and exposure of the proceeds to creditors — three effects sellers most often discover too late.
• The rescission right and its deadline, described below.
• Contact and complaint information, so a seller knows the transaction is regulated and by whom.

Contracts themselves must be on forms the Department has reviewed, which standardizes terms and prevents buried waivers. Timing matters too: disclosures must come early enough to inform the decision, not arrive at the closing table as a signature formality.

Two practical notes. First, disclosure is a floor, not analysis — a form listing “alternatives” is not the same as a side-by-side comparison of surrender value, restructuring illustrations, and competing bids, which sellers should demand separately. Second, keep the entire disclosure package permanently; it doubles as tax documentation and as evidence if a dispute arises. The broader consumer-protection architecture across states is surveyed in life settlement consumer protections.

Provision	What the Act Requires	Who It Protects Against
Licensing (brokers & providers)	DOBI license required to negotiate or purchase settlements	Fly-by-night intermediaries with no regulator to answer to
Broker role definition	Broker represents the policyholder in negotiating the settlement	Intermediaries quietly working for the buyer
Written disclosures	Price, compensation, alternatives, tax/benefit/creditor effects, rescission terms	Hidden commissions and uninformed decisions
Approved contract forms	Settlement contracts on Department-reviewed forms	Buried waivers and one-sided terms
Waiting periods + hardship exceptions	New policies generally cannot be settled in their first years, absent defined hardships	STOLI promoters manufacturing policies to flip
Escrow closing	Independent escrow holds funds until the carrier confirms transfer	Buyers who take ownership before paying
Rescission right	Post-closing cancellation window; death during window unwinds the sale	Irreversible regret and deathbed value loss
Privacy limits	Restricted use and sharing of medical and identity information	Resale or marketing use of the insured’s health file
Fraud provisions	STOLI banned; false statements and unlicensed activity punishable	The schemes that created the need for the Act

Timing Rules: Waiting Periods and Hardship Exceptions

The Act restricts when a policy may be settled, primarily to choke off manufactured transactions. The core device is a waiting period measured from the policy’s issue date: newly issued policies generally cannot be settled during their first years in force. New Jersey’s framework — like the NAIC model it parallels — pairs a baseline period with a longer one for policies bearing hallmarks of investor origination, and the practical industry rule that a policy should be at least two years old (past its contestability period) before settlement fits inside these limits.

The logic is anti-STOLI: if a policy cannot be flipped quickly, there is little economic room for schemes in which investors induce seniors to take out coverage purely to sell it. The waiting period forces policies to begin life as genuine insurance.

But rigid waiting periods would trap people whose circumstances collapse soon after buying legitimate coverage, so the Act allows earlier settlement upon defined hardships, which typically include:

• Terminal or chronic illness diagnosed after issue — the classic viatical scenario;
• Death of a spouse;
• Divorce;
• Retirement from full-time employment;
• Physical or mental disability; and
• Certain financial disqualifications or insolvency events, such as bankruptcy.

Sellers invoking a hardship exception should expect to document it — providers must maintain evidence supporting an early settlement. For most New Jersey sellers this section never bites: the typical settled policy is a decade or more old. Where it matters is at the margins, and the margins are exactly where fraud lives. A fuller statutory context sits in our complete New Jersey life settlements guide.

Rescission, Escrow, and Privacy: The Transactional Safeguards

Three mechanical protections govern the closing itself, and together they answer the three ways a settlement could go wrong at the finish line.

Rescission — the wrong-decision safeguard. New Jersey law gives sellers a post-contract cancellation right consistent with the national 15–30 day pattern. Within the window, the seller may unwind the sale, return the proceeds, and keep the policy. Critically, the framework also addresses death during the window: if the insured dies before rescission lapses, the settlement is generally treated as rescinded — the buyer gets its money back and the death benefit flows to the original beneficiaries. This prevents the grim scenario of a family losing a full death benefit for a fraction of its value days before it would have paid.

Escrow — the payment safeguard. Settlement funds must move through an independent escrow arrangement: the purchase price is deposited with an escrow agent before ownership documents go to the insurer, and released to the seller promptly once the carrier confirms the transfer of ownership and beneficiary. The seller is never in the position of having signed away the policy while waiting on a buyer’s promise to pay.

Privacy — the information safeguard. Settling a policy requires handing over the most sensitive records a person has: medical files and identity information. The Act restricts how brokers, providers, and their contractors may use and share the insured’s identity and health information, generally limiting disclosure to what effectuating the settlement requires (life expectancy underwriting, carrier verification) and barring resale or marketing use without authorization. After closing, contact with the insured for status updates is also constrained — the buyer’s periodic “are you still living” contacts are limited in frequency and channeled through designated parties.

The Anti-Fraud Provisions: STOLI and Its Penalties

The Act devotes substantial machinery to fraud, and the centerpiece is the prohibition of stranger-originated life insurance (STOLI) — arrangements that manufacture a policy for investors rather than insure a genuine risk. The recurring pattern: promoters persuade a senior to apply for a large policy (often with promises of “free insurance” or upfront cash, financed by a non-recourse loan), intending from inception that ownership will pass to investors who lack any insurable interest in the senior’s life. STOLI corrupts the market’s foundation — insurable interest at issuance — and it is precisely what the Act’s waiting periods, origination scrutiny, and fraud definitions target.

Beyond STOLI, the Act’s fraudulent-acts provisions reach conduct across the transaction’s life cycle, including:

• Knowingly presenting false information in settlement applications, life expectancy submissions, or contract documents;
• Concealing material facts — including an insured’s clean bill of health in a viatical application, or a policy’s true origination history;
• Transacting without a license, or aiding those who do;
• Interference and coercion in the settlement process.

Consequences stack across three tracks: administrative (DOBI license denial, suspension, revocation, and monetary penalties), civil (contract remedies and Department enforcement actions), and criminal (settlement fraud is punishable as insurance fraud under New Jersey law). Carriers, brokers, and providers also carry reporting obligations when they suspect fraud.

For sellers, the practical import is protective: the same provisions that punish fraud make the legitimate channel safe. A licensed, escrowed, fully disclosed transaction is one in which every counterparty has a license to lose. The national anti-fraud framework this mirrors is discussed in how are life settlements regulated.

Using the Act: A New Jersey Seller’s Compliance Checklist

Statutes protect the people who invoke them. Distilled into a working checklist, the Act tells every New Jersey policyholder to:

• Verify licenses first. Confirm the broker and every bidding provider with DOBI before sharing policy or medical information. Unlicensed contact is itself a violation worth reporting.
• Confirm your policy’s timing posture. If the policy is more than a few years old, waiting periods are a non-issue; if it is young, identify which hardship exception applies and gather documentation.
• Demand the disclosure package early — gross price, broker compensation, alternatives, tax and benefit warnings, rescission terms — and read it before, not at, signing.
• Insist on escrow. No legitimate New Jersey closing pays the seller directly from a buyer’s operating account or asks the seller to transfer ownership before funds are secured.
• Guard the medical file. Sign authorizations that name specific recipients and purposes; the Act’s privacy limits are strongest when your consent is narrow.
• Calendar the rescission deadline the day you sign, and treat the window as a genuine second-look period — re-run the after-tax math, confirm benefit effects, tell your family.
• Report violations. Complaints to DOBI’s consumer services unit trigger the enforcement machinery; the Department can act against licensees and refer fraud for prosecution.

None of this requires a lawyer to start, though sellers with Medicaid exposure, trusts, or creditor issues should involve one. The Act was written because an earlier generation of sellers had no rulebook. The current generation’s job is simpler: transact only inside it.

---

Frequently Asked Questions

Does the New Jersey Viatical Settlements Act apply if I’m healthy and just selling an unneeded policy?

Yes. Although “viatical” historically referred to sales by terminally ill policyholders, New Jersey’s statute uses the term as an umbrella covering ordinary life settlements by healthy older insureds as well. A healthy 75-year-old selling a universal life policy gets the same statutory protections — licensed counterparties, written disclosures, escrowed closing, and a rescission window — as a terminally ill seller. What changes with health status is primarily the tax treatment and certain timing exceptions, not the regulatory safeguards.

What is the difference between a viatical settlement and a life settlement under New Jersey law?

Functionally, New Jersey regulates them as one transaction type. The industry distinction — viatical settlements involve terminally or chronically ill insureds, life settlements involve older insureds who are not dying — matters mainly for taxes: viatical proceeds are often entirely tax-free under IRC Section 101(g) when life expectancy is under 24 months, while life settlement proceeds follow the three-tier framework of IRS Rev. Rul. 2009-13. Under the Act itself, both require licensed brokers and providers, disclosures, escrow, and rescission rights.

Who enforces the Viatical Settlements Act in New Jersey?

The New Jersey Department of Banking and Insurance. DOBI licenses viatical settlement brokers and providers, reviews the contract and disclosure forms used with New Jersey residents, accepts and investigates consumer complaints, and can deny, suspend, or revoke licenses and impose monetary penalties for violations. Settlement fraud can also be prosecuted criminally as insurance fraud. Consumers can verify licenses and file complaints through the Department at state.nj.us/dobi, which is the first stop whenever something about a solicitation looks wrong.

How soon after buying a life insurance policy can I sell it in New Jersey?

Generally not during the policy’s first years. Like the NAIC model framework, New Jersey restricts settling newly issued policies — a waiting period designed to prevent stranger-originated life insurance schemes — and as a practical matter buyers want policies past their two-year contestability period. The Act allows earlier sales for documented hardships such as terminal or chronic illness, death of a spouse, divorce, retirement, or disability. Since most settled policies are a decade or more old, the waiting period rarely affects ordinary sellers.

What disclosures am I entitled to before signing a life settlement contract in NJ?

Before you sign, you must receive written disclosure of the gross purchase price, the broker’s compensation, alternatives to settling (surrender, policy loans, reduced paid-up coverage, accelerated death benefits), and the consequences of selling — including possible taxes, effects on means-tested benefits like Medicaid, and creditor exposure of the proceeds. You must also be told about your rescission right and how to contact the regulator. Contracts must use Department-reviewed forms. Keep the entire package; it doubles as tax documentation.

Can I cancel a life settlement after closing under New Jersey law?

Yes, within the rescission window. New Jersey follows the national pattern of a 15 to 30 day post-closing cancellation right: return the proceeds and the sale is unwound, with your policy reinstated. The framework also protects your beneficiaries if the insured dies during the window — the settlement is generally treated as rescinded, the buyer recovers its payment, and the full death benefit goes to the original beneficiaries. After the window closes, the transaction is permanent and the buyer owns the policy outright.

What counts as STOLI, and why is it illegal in New Jersey?

Stranger-originated life insurance is any arrangement where a policy is taken out primarily as an investment for people with no insurable interest in the insured’s life — typically promoters offering a senior “free insurance” or upfront cash, with a plan from inception to transfer the policy to investors. It is prohibited because it corrupts the insurable-interest foundation of life insurance and exploits seniors as policy-manufacturing vehicles. The Act attacks STOLI through waiting periods, origination scrutiny, fraud definitions, and administrative, civil, and criminal penalties.

Is my medical information protected when I sell my life insurance policy?

Yes. The Act restricts how brokers, providers, and their vendors may use and share the insured’s identity and health information, generally limiting it to what the settlement itself requires — life expectancy underwriting, carrier verification, and closing mechanics — and barring broader use without your authorization. Post-sale contact with the insured to track status is also limited in frequency. Practical protection starts with you: sign medical authorizations that name specific recipients and purposes rather than open-ended releases.

Related Reading

• Life Settlements New Jersey Complete Guide
• Nj Dobi Life Settlement Licensing
• Life Settlement Consumer Protections
• How Are Life Settlements Regulated

---

Pine Lake Life Solutions does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.